Immediate Impact
10 from Science/Nature 61 standout
Citing Papers
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Works of Anatoly Tiulpakov being referenced
Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study
2022
Efficacy and safety of volanesorsen for the treatment of metabolic complications in patients with familial partial lipodystrophy: results of the BROADEN study
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anatoly Tiulpakov | 612 | 770 | 445 | 124 | 1.5k | |
| Yoshimasa Shishiba | 482 | 962 | 301 | 115 | 2.0k | |
| Dionisios Chrysis | 735 | 529 | 433 | 64 | 1.8k | |
| Noriyuki Katsumata | 908 | 665 | 524 | 89 | 1.8k | |
| Nadia Sakati | 803 | 339 | 533 | 77 | 1.6k | |
| Dorothy I. Shulman | 460 | 979 | 593 | 69 | 1.8k | |
| Zoran Gucev | 802 | 786 | 403 | 105 | 1.9k | |
| Ece Böber | 384 | 546 | 444 | 139 | 1.6k | |
| Gönül Öçal | 454 | 467 | 378 | 102 | 1.2k | |
| Klaus Mohnike | 538 | 980 | 667 | 106 | 1.9k | |
| Zeynep Şıklar | 385 | 410 | 364 | 132 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...